Insights Into the Management of Lower-Risk Myelodysplastic Syndromes (LR-MDS) 2025

Perspectives of community physicians from across the US into the management of LR-MDS

Southeast – March 21, 2025
Purchase Report

Faculty Chair

Amer Zeidan, MBBS

Yale School of Medicine, New Haven, CT, USA

More Information

  • Atlanta, GA
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, West Virginia

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated roundtable discussion focusing on current treatment practices in and understanding of LR-MDS
  • Disease state and data presentations were developed in conjunction with a national or regional oncology expert

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.